• Home
  • About
  • Partners
  • Products
  • US Products
  • Publications
  • News
  • Calendars
  • Contact

Providing healthcare professionals with state-of-the-art products for the benefit of patients around the world through creativity, innovation and quality

 



ESTAR MEDICAL

Innovation With Care 

  • History
  • Quality Assurance
  • Medical Innovation
  • Management Team
  • Scientific Board

Estar Medical business partners are leading providers of superior medical products in the healthcare arena, sharing the values of innovation, quality and care.

  • A.R.T
  • Regenerative Medicine
  • Blood Collection
  • Urine Collection
  • Other products
  • Regenerative Medicine
  • A.R.T
  • Regenerative Medicine
  • Blood Collection
  • Urine Collection
  • A.R.T
  • Regenerative Medicine
  • Blood Collection
  • A.R.T
  • Regenerative Medicine
  • General Medicine
Estar Technologies Ltd.

Address: 15 Hamerkava st.

Holon 58851 ISRAEL

Telephone:  +972-3-5596414

Fax:  +972-3-5596424

email:  sales@estar-medical.com

  • Origio Introduces EmbryoGen® - the world’s first IVF medium with natural growth factor documenting a 44% increased chance of success!

     

    At ESHRE 2011 in Stockholm ORIGIO will introduce the new product EmbryoGen® – the  first IVF medium with GM-CSF growth factor.

  • Crio Bio System - FDA approved HSV straws
    Crio Bio System has announced that the HSV™ High Security Vitrification straws have received FDA 510 (k) clearance for 4-8 cell and blastocyst stage embryos.
  • Estar launches in Israel the Benchtop Incubator BT37 from Origio/Planer
    The ultimate culture environment
  • Estar launches in Israel the Cryopette® from Origio
    Cryopette® - Making Vitrification Easier
  • Vitrolife acquires Conception Technologies, USA.

    Vitrolife expands its IVF product portfolio through acquisition in the USA.

     

Vitrolife acquires Conception Technologies, USA.

Vitrolife expands its IVF product portfolio through acquisition in the USA.

 

Vitrolife is acquiring the business in Conception Technologies, USA. This means that Vitrolife will broaden their IVF product portfolio, increase cost-efficient production capacity and increase its market share, above all in North America. 

For more information - click here

Project Management: Yoram Bar-Sela | Copywriting: Linda Triffon Graphic Design: Ouriel Amgar | Programming: WebVortex